Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
27,065,518
-
Share change
-
+1,903,032
-
Total reported value
-
$508,505,214
-
Put/Call ratio
-
188%
-
Price per share
-
$18.79
-
Number of holders
-
106
-
Value change
-
+$36,985,585
-
Number of buys
-
58
-
Number of sells
-
42
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2018
As of 31 Mar 2018,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,065,518 shares.
The largest 10 holders included
TRV GP III, LLC, FMR LLC, BB BIOTECH AG, BlackRock Inc., Casdin Capital, LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, EVENTIDE ASSET MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.